Reduction in U.S. direct spending on originator biologics as of 2018

Published by
Matej Mikulic,
Jun 18, 2024
This statistic depicts the projected savings in spending on originator biologics in the U.S. as of 2018. The projections are provided by different agencies for several time ranges. According to the projection by ESI (Express Scripts, Inc.), some 250 billion U.S. dollars will be saved due to the use of biosimilars in the United States between 2014 and 2024.

Projected reduction in U.S. biosimilar direct spending on originator biologics as of 2018 (in billion U.S. dollars)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

February 2018

Region

United States

Survey time period

as of 2018

Supplementary notes

CBO = Congressional Budget Office;
RAND = RAND Corporation;
QI = QuintilesIMS (IQVIA);
ESI = Express Scripts Inc.
* Actually, the RAND gives a range of 40-93 billion U.S. dollars.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical industry in Spain "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical industry in Spain

Overview

6

International trade

6

Pharmaceutical sales

6

Pharmaceutical expenditure of the National Health System

6

Research and development

6

Company rankings

6

Further related statistics

19

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceuticals in IndiaGlobal pharmaceutical industryPharmaceutical industry in JapanPharmaceutical industry in ChinaPharmaceutical industry in South Korea
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.